MD4231B1 - Medicament based on troxerutin and carbazochrome for the treatment of portal gastropathies in hepatic cirrhosis - Google Patents
Medicament based on troxerutin and carbazochrome for the treatment of portal gastropathies in hepatic cirrhosisInfo
- Publication number
- MD4231B1 MD4231B1 MDA20120102A MD20120102A MD4231B1 MD 4231 B1 MD4231 B1 MD 4231B1 MD A20120102 A MDA20120102 A MD A20120102A MD 20120102 A MD20120102 A MD 20120102A MD 4231 B1 MD4231 B1 MD 4231B1
- Authority
- MD
- Moldova
- Prior art keywords
- gastropathies
- portal
- treatment
- carbazochrome
- troxerutin
- Prior art date
Links
Abstract
The invention relates to medicine, particularly to hepatology and can be used for the treatment of portal gastropathies in hepatic cirrhosis.Summary of the invention consists in that a medicament is used on the basis of troxerutin and carbazochrome, in a dose of 150 mg and, respectively, 1.5 mg, for the treatment of portal gastropathies in hepatic cirrhosis. At the same time, the medicament is administered 1 tablet, 2…3 times daily, per os, during 14…30 days.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MDA20120102A MD4231C1 (en) | 2012-11-08 | 2012-11-08 | Medicament based on troxerutin and carbazochrome for the treatment of portal gastropathies in hepatic cirrhosis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MDA20120102A MD4231C1 (en) | 2012-11-08 | 2012-11-08 | Medicament based on troxerutin and carbazochrome for the treatment of portal gastropathies in hepatic cirrhosis |
Publications (2)
Publication Number | Publication Date |
---|---|
MD4231B1 true MD4231B1 (en) | 2013-06-30 |
MD4231C1 MD4231C1 (en) | 2014-01-31 |
Family
ID=48749682
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MDA20120102A MD4231C1 (en) | 2012-11-08 | 2012-11-08 | Medicament based on troxerutin and carbazochrome for the treatment of portal gastropathies in hepatic cirrhosis |
Country Status (1)
Country | Link |
---|---|
MD (1) | MD4231C1 (en) |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1985003864A1 (en) * | 1984-03-01 | 1985-09-12 | Casley Smith John Royle | Treatment of high protein oedemas by direct application of benzo-pyrones |
CH671021A5 (en) * | 1987-05-07 | 1989-07-31 | Espanola Prod Quimicos | Prodn. of hydroxy:ethylated diosmin mixts. - useful for treating intoxication |
FR2661610B1 (en) * | 1990-05-02 | 1994-09-30 | Rhone Poulenc Sante | NOVEL LYOPHILIZED FORM OF DIOSMINE AND ITS PREPARATION. |
FR2661830B1 (en) * | 1990-05-11 | 1992-09-04 | Corbiere Jerome | NOVEL PHARMACEUTICAL COMPOSITIONS BASED ON FLAVONOSIDE. |
FR2668705A1 (en) * | 1990-11-06 | 1992-05-07 | Bouchara Sa | Novel skin preparations having a phlebotonic action and process for preparing them |
FR2692145B1 (en) * | 1992-06-10 | 1995-05-05 | Bellon Labor Sa Roger | New composition for topical use containing diosmin. |
FR2726469B1 (en) * | 1994-11-08 | 1996-12-13 | Adir | PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION OF FLAVONOIDS |
JPH08301757A (en) * | 1995-05-10 | 1996-11-19 | Kureha Chem Ind Co Ltd | Hsp47 synthesis suppressing agent |
BE1011151A3 (en) * | 1997-05-13 | 1999-05-04 | Jose Remacle | Use of a pharmaceutical composition for treating and / or preventing ischemia. |
FR2778663B1 (en) * | 1998-05-15 | 2001-05-18 | Coletica | NOVEL ESTERS OF FLAVONOIDS, THEIR USE IN COSMETICS, DERMOPHARMACY, PHARMACY AND AGRI-FOOD |
JP2000023635A (en) * | 1998-07-10 | 2000-01-25 | M P G Kk | Granule nutrient auxiliary food |
KR20000019717A (en) * | 1998-09-15 | 2000-04-15 | 박호군 | Composition comprising rutin and quercetin for preventing and treating hyperlipidemia, arteriosclerosis and liver disease |
KR100291141B1 (en) * | 1998-09-15 | 2001-07-12 | 박호군 | Composition for preventing and treating atherosclerosis and hyperlipidemia, comprising diosmin |
CA2425912A1 (en) * | 2000-09-11 | 2002-03-14 | Michael D. Stander | Use of buchu extracts for hypertension |
KR100291144B1 (en) * | 2000-10-06 | 2001-05-15 | 박호군 | Composition for preventing and treating atherosclerosis and hyperlipidemia, comprising diosmin |
KR100291145B1 (en) * | 2000-10-06 | 2001-05-15 | 박호군 | Composition for preventing and treating atherosclerosis, hyperlipidemia, hepatic diseases and glycosemia, comprising neohesperidin dihydrochalcone |
FR2845597B1 (en) * | 2002-10-11 | 2005-03-11 | Innothera Lab Sa | DRY ORAL FORMULATION CONTAINING DIOSMINE AS A PHARMACEUTICAL FORM OF A TABLET TO BE CROQUERED |
US20040132816A1 (en) * | 2003-01-06 | 2004-07-08 | Liao Medical Corporation | Lipid metabolism and fructus crataegus |
FR2857665B1 (en) * | 2003-07-16 | 2006-02-10 | Centre Nat Rech Scient | NOVEL FLAVON DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME |
ITMI20050517A1 (en) * | 2005-03-30 | 2006-09-30 | Therapicon Srl | PHARMACEUTICAL COMPOSITION OF A TYPICAL MICROCRYSTALLINE FRACTION OF FLAVONOIDS |
CN100444847C (en) * | 2006-01-11 | 2008-12-24 | 刘展欣 | Micronize diosmin and hesperidine composition suppository |
MX2007011002A (en) * | 2007-09-07 | 2009-03-09 | World Trade Imp Export Wtie Ag | Pharmaceutical composition combining various venotonic and vasoprotective agents for the treatment of chronic venous insufficiency. |
-
2012
- 2012-11-08 MD MDA20120102A patent/MD4231C1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
MD4231C1 (en) | 2014-01-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY159353A (en) | Pirfenidone treatment for patients with atypical liver function | |
NZ732507A (en) | Improved compositions for treating muscular dystrophy | |
EA201591679A1 (en) | METHOD OF NON-TOXIC TREATMENT OF ABSTINENT, CAUSED BY MEDICINE | |
TN2017000554A1 (en) | Novel combination for use in the treatment of cancer | |
CL2014002935A1 (en) | Method to treat a human patient with multiple sclerosis with laquinimod, at a daily dose of about 1.2mg; an oral unit dosage form of 1.2 mg of laquinimod and a carrier | |
MX2011007589A (en) | Treatment of a cancer using a combination of bendamustine and an anti-cd20 antibody. | |
JP2013155188A5 (en) | ||
UA105191C2 (en) | Treatment with pirfenidone of patients with abnormal liver function | |
MX2016015437A (en) | Combination comprising a glucocorticoid and edo-s101. | |
MX2017003780A (en) | Pharmaceutical composition for treating ulcerative colitis. | |
MX2019008817A (en) | Extended-release formulation for reducing the frequency of urination and method of use thereof. | |
MX2016008027A (en) | Use of laquinimod to delay huntington's disease progression. | |
IN2015DN02999A (en) | ||
MX2018011293A (en) | Prolonged release pharmaceutical composition comprising cysteamine or salt thereof. | |
MD4231C1 (en) | Medicament based on troxerutin and carbazochrome for the treatment of portal gastropathies in hepatic cirrhosis | |
MD4232B1 (en) | Medicament based on troxerutin and carbazochrome for the treatment of progressive hepatic cirrhosis associated with heart failure | |
MX2016006375A (en) | A combination of dosage units for use in the treatment of pre-term labour condition. | |
MD4458B1 (en) | Use of Polybiolin drug in patients with liver cirrhosis | |
MD3987C2 (en) | Use of Diosmine for the treatment of advancing hepatic cirrhosis associated with cardiac insufficiency | |
MX2015016678A (en) | Pharmaceutical formulations comprising agomelatine in the form of agomelatine co-crystal with an organic acid. | |
MD3986C2 (en) | Use of Diosmine for the treatment of portal gastropathies in the hepatic cirrhosis | |
UA95834U (en) | Method for treating acute ischemic stroke | |
UA82250U (en) | Method for treating patients with non-alcoholic fatty liver disease | |
UA93070U (en) | Method of treatment of mucocutaneous candidiasis treatment with the patients having chronic pancreatitis | |
NZ600486A (en) | Pirfenidone treatment for patients with atypical liver function |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG4A | Patent for invention issued | ||
KA4A | Patent for invention lapsed due to non-payment of fees (with right of restoration) |